Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Monica Milla"'
Autor:
Jenny Roselli, Tommaso Innocenti, Erica Nicola Lynch, Laura Parisio, Giuseppe Macrì, Monica Milla, Tommaso Mello, Andrea Galli, Stefano Milani, Mirko Tarocchi
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2020 (2020)
Azathioprine is a cornerstone of the therapy of Crohn’s disease. Unfortunately, infections and malignancies are relatively common adverse effects related to this drug; however, cirrhosis is exceptionally reported as a side effect. We report the cas
Externí odkaz:
https://doaj.org/article/aaef8bfc606d41439ef8844f2a12c1a7
Autor:
Jenny Roselli, Tommaso Innocenti, Erica Nicola Lynch, Laura Parisio, Pasquale Apolito, Tommaso Mello, Giuseppe Macrì, Monica Milla, Maria Rosa Biagini, Mirko Tarocchi, Stefano Milani, Andrea Galli
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2020 (2020)
Stevens–Johnson syndrome (SJS) is a severe mucocutaneous adverse drug reaction with a relatively high mortality rate. SJS is described during herpes simplex virus type 1 (HSV1) infection and, rarely, even during adalimumab therapy. We report the ca
Externí odkaz:
https://doaj.org/article/f308cf6d9ec948cf81cfeb8d1127bda6
Autor:
Gabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, Daniela Pugliese, Rocco Spagnuolo, Anna Viola, Francesco Cocomazzi, Annalisa Aratari, Edoardo Vincenzo Savarino, Paola Balestrieri, Sara Onali, Chiara Viganò, Davide Giuseppe Ribaldone, Tommaso Innocenti, Anna Testa, Simone Saibeni, Giuseppe Privitera, Monica Milla, Alessandro Armuzzi, Massimo Claudio Fantini, Gionata Fiorino
Publikováno v:
United European Gastroenterology Journal. 11:271-281
Autor:
Gabriele Dragoni, Matteo Gottin, Tommaso Innocenti, Erica Nicola Lynch, Siro Bagnoli, Giuseppe Macrì, Andrea Giovanni Bonanomi, Beatrice Orlandini, Francesca Rogai, Stefano Milani, Andrea Galli, Monica Milla, Maria Rosa Biagini
Publikováno v:
Journal of Crohn's and Colitis.
Background and Aims Intestinal ultrasound [IUS] is widely accepted as a reliable tool to monitor Crohn’s disease [CD]. Several IUS scores have been proposed, but none has been formally accepted by international organizations. Our aim here was to co
Autor:
Lara Zangana, Adrián Valls, Josep Munuera, Mariano Werner, Sebastián Remollo, Laura Dorado, Joaquín Serena, Josep Puig, Natalia Pérez de la Ossa, Meritxell Gomis, Alejandro Bustamante, Belen Flores Pina, Marina Martinez, Carlos Castaño, Lucia Muñoz, Anna Massuet, Jonathan M. Coutinho, Mònica Millán, María Hernández-Pérez
Publikováno v:
Journal of Stroke, Vol 26, Iss 3, Pp 450-453 (2024)
Externí odkaz:
https://doaj.org/article/ac6d5435c2ce4a679e57e34adf29994f
Autor:
Fabio Salvatore Macaluso, Claudio Papi, Ambrogio Orlando, Stefano Festa, Daniela Pugliese, Stefanos Bonovas, Claudia Pansieri, Daniele Piovani, Gionata Fiorino, Massimo Claudio Fantini, Flavio Caprioli, Marco Daperno, Alessandro Armuzzi, Lorenzo Bertani, Cristina Bezzio, Giorgia Bodini, Fabrizio Bossa, Andrea Buda, Emma Calabrese, Federica Furfaro, Salvatore Leone, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Enrica Previtali, Mariabeatrice Principi, Sara Renna, Davide Giuseppe Ribaldone, Antonio Rispo, Fernando Rizzello, Simone Saibeni, Gianluca Matteo Sampietro, Edoardo Savarino, Anna Testa, Angela Variola, Angelo Viscido, Sandro Ardizzone, Livia Biancone, Maria Cappello, Fabiana Castiglione, Rachele Ciccocioppo, Michele Comberlato, Francesco Costa, Renata D'Incà, Silvio Danese, Antonio Di Sabatino, Walter Fries, Paolo Gionchetti, Giovanni Latella, Francesco Manguso, Mauro Mastronardi, Gianmichele Meucci, Monica Milla, Maria Lia Scribano, Maurizio Vecchi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::525fb169fbf066ac32009fc6660b392e
https://hdl.handle.net/2318/1897732
https://hdl.handle.net/2318/1897732
Autor:
Fabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, Antonella Contaldo, Alessia Todeschini, Simone Saibeni, Cristina Bezzio, Fabiana Castiglione, Olga Maria Nardone, Rocco Spagnuolo, Massimo Claudio Fantini, Gaia Riguccio, Flavio Caprioli, Chiara Viganò, Carla Felice, Gionata Fiorino, Carmen Correale, Giorgia Bodini, Monica Milla, Giulia Scardino, Marta Vernero, Federico Desideri, Mariella Mannino, Giuseppe Rizzo, Ambrogio Orlando, Arnaldo Amato, Marta Ascolani, Giulio Calabrese, Angelo Casà, Michele Comberlato, Francesco Simone Conforti, Manuela De Bona, Maria Giulia Demarzo, Patrizia Doldo, Gabriele Dragoni, Federica Furfaro, Giacomo Mulinacci, Oriana Olmo, Nicole Piazza O'Sed, Salvatore Paba, Simona Radice, Sara Renna, Davide Giuseppe Ribaldone, Giulia Rizzuto
Background: Patients on immunosuppressive drugs have been excluded from COVID-19 vaccines trials, creating concerns regarding their efficacy. Aims: To explore the humoral response to COVID-19 vaccines in patients with inflammatory bowel disease (IBD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14da005a8d755dee00a7e6a3220c4ee0
http://hdl.handle.net/10281/392946
http://hdl.handle.net/10281/392946
Autor:
Tommaso Innocenti, Jenny Roselli, Alice Taylor, Gabriele Dragoni, Erica Nicola Lynch, Claudia Campani, Matteo Gottin, Siro Bagnoli, Giuseppe Macrì, Francesca Rogai, Stefano Milani, Andrea Galli, Monica Milla
Publikováno v:
Journal of digestive diseasesREFERENCES. 23(8-9)
Inflammatory bowel disease (IBD) can affect young and reproductively active patients. Our aim was to analyze pregnancy outcomes in a large cohort of women with IBD.All women with at least one pregnancy were given a questionnaire regarding the outcome
Autor:
Riccardo Morganti, Ivano Biviano, Siro Bagnoli, Francesca Calella, Sara Naldini, E.N. Lynch, Lorenzo Bertani, Linda Ceccarelli, Paolo Lionetti, Simona Maltinti, Alberto Pieraccini, G. Tapete, Moira Minciotti, Francesca De Nigris, Martina Giannotta, Francesco Costa, Maria Gloria Mumolo, Monica Milla, Silvia Rentini
Publikováno v:
Inflammatory Bowel Diseases. 28:62-69
Background Few data are currently available about SB5 in inflammatory bowel diseases (IBD). The aim of this study was to assess the effectiveness and safety of SB5 in a cohort of patients with IBD in stable remission switched from the adalimumab (ADA
Autor:
Giuseppe Macrì, Francesca Rogai, Stefano Milani, L. Parisio, E.N. Lynch, Monica Milla, Siro Bagnoli, Andrea Galli, Tommaso Innocenti, Jenny Roselli, Mirko Tarocchi, Gabriele Dragoni, Pasquale Apolito
Publikováno v:
European journal of gastroenterologyhepatology. 33(1S Suppl 1)
Vedolizumab is a gut-selective anti-integrin (α4β7) antibody for the treatment of inflammatory bowel disease with a well-known optimal safety profile. We aimed to compare its risk of infections with that of anti-TNF drugs and ustekinumab in patient